Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=3&sort=title
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=title", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1392&sort=title", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=4&sort=title", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=2&sort=title" }, "data": [ { "type": "Grant", "id": "5921", "attributes": { "award_id": "3U24AA020801-10S2", "title": "1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" ], "program_reference_codes": [], "program_officials": [ { "id": 20228, "first_name": "Deidra", "last_name": "Roach", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2011-09-15", "end_date": "2022-08-31", "award_amount": 111144, "principal_investigator": { "id": 20229, "first_name": "GEETANJALI", "last_name": "CHANDER", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 20230, "first_name": "MARY E", "last_name": "MCCAUL", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 344, "ror": "https://ror.org/00za53h95", "name": "Johns Hopkins University", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true }, "abstract": "This competitive renewal application for the Alcohol Research Consortium on HIV (ARCH) builds on and extends our very successful administrative and research accomplishments during our initial NIAAA funding period. ARCH is integrated into a well-established, scientifically productive, national HIV clinical cohort, the CFAR Network of Integrated Clinical systems (CNICS), a network of 8 clinical cohorts and over 30,000 persons living with HIV (PLWH) across the United States. This dynamic cohort provides an ideal scientific platform for long-term study of HIV and alcohol through the collection of comprehensive clinical data and specimens as well as uniformly-collected patient reported outcomes. The ARCH consortium consists of the Administrative Core (ARCH-AC), the epidemiological research component (ARCH-ERA), and an intervention research component (ARCH- IRA). In addition, we have embedded a nascent resource core into each of the research components to capitalize on our expertise and expand our capacity in two new and critical areas of high relevance to HIV and alcohol services and research: the Biostatistics Core (housed in the epidemiology grant ARCH-ERA) and an eHealth Technology Core (housed in the intervention grant ARCH-IRA). The overarching goal of our consortium is to improve clinical outcomes and reduce health disparities among PLWH with alcohol misuse through development and testing of tailored interventions (ARCH-IRA) that are informed by real-time data collection and analysis (ARCH-ERA). Specific themes addressed by our consortium include health disparities, precision medicine, implementation science, state-of-the-art biostatistical methodology, and eHealth technology. The ARCH Administrative Core (AC), the focus of this application, is the U24 that provides the infrastructure for oversight, coordination and direction to the consortium, and facilitates the scientific goals of the epidemiology and intervention components of ARCH. The structure includes: an executive committee; a research steering committee which includes a scientific advisory board; key scientific working groups to conceptualize and implement study aims. ARCH-AC is co-led by national experts in alcohol use disorders and HIV, who have over 30 years of combined scientific experience in conducting epidemiologic and clinical research in HIV/AIDS. The AC provides the critical infrastructure to: 1)Facilitate communication, collaboration and integration among ARCH components and investigators, NIAAA collaborators, Scientific Advisory Board, CHAART and other alcohol/HIV consortia; 2)Oversee implementation of the ARCH scientific epidemiologic and interventional aims; 3)Optimize coordination of ARCH resources among the research projects and with outside groups, particularly the data repositories, epidemiologic/ biostatistics support and the investigational expertise; 4)Promote scientific participation of junior investigators new to the field of alcohol and or HIV; 5)Support dissemination of information by ARCH investigators through presentations, publications, web site maintenance and other strategies for public communication.", "keywords": [ "AIDS/HIV problem", "Address", "Alabama", "Alcohol consumption", "Alcohols", "Area", "Biometry", "Biostatistics Core", "Characteristics", "Clinical", "Clinical Data", "Clinical Research", "Cognition", "Collaborations", "Collection", "Committee Members", "Communication", "Communities", "Continuity of Patient Care", "Data Analyses", "Data Collection", "Development", "Drug usage", "Epidemiology", "Faculty", "Foundations", "Funding", "Goals", "Grant", "HIV", "Health", "Health Services Research", "Hepatitis C", "Information Dissemination", "Infrastructure", "Interdisciplinary Study", "Intervention", "Intervention Studies", "Investigation", "Knowledge", "Leadership", "Link", "Longitudinal Studies", "Maintenance", "Mental Health", "Methodology", "National Institute on Alcohol Abuse and Alcoholism", "Outcome", "Patient Outcomes Assessments", "Patients", "Persons", "Primary Health Care", "Publications", "Research", "Research Personnel", "Research Project Grants", "Resources", "Services", "Specimen", "Structure", "System", "Technology", "Testing", "Time", "Treatment outcome", "United States", "United States National Institutes of Health", "Universities", "Visit", "Washington", "Work", "acronyms", "adjudicate", "age related", "alcohol epidemiology", "alcohol measurement", "alcohol misuse", "alcohol research", "alcohol services", "alcohol use disorder", "brief intervention", "burden of illness", "clinical care", "cohort", "comorbidity", "computerized", "data repository", "eHealth", "epidemiology study", "experience", "health disparity", "implementation science", "improved", "medical schools", "precision medicine", "social", "spelling", "technological innovation", "treatment disparity", "web site", "working group" ], "approved": true } }, { "type": "Grant", "id": "5711", "attributes": { "award_id": "3R34DA050291-01S3", "title": "1/4 Investigation of opioid exposure and neurodevelopment (iOPEN)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 19698, "first_name": "Vani", "last_name": "Pariyadath", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-09-30", "end_date": "2021-03-31", "award_amount": 267279, "principal_investigator": { "id": 19699, "first_name": "Damien A", "last_name": "Fair", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 19700, "first_name": "Alice M", "last_name": "Graham", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 765, "ror": "https://ror.org/009avj582", "name": "Oregon Health & Science University", "address": "", "city": "", "state": "OR", "zip": "", "country": "United States", "approved": true }, "abstract": "The ongoing COVID-19 pandemic has led to significant changes in social, economic and health resource availability and associated escalations in substance use and mental health problems. The consequences of the pandemic for pregnant and postpartum individuals and their offspring will reveal themselves over the next several decades as these children become adolescents and young adults. The current proposal seeks to take advantage of a unique opportunity to continue and enrich an ongoing data collection effort with potential to reveal mechanisms through which the COVID-19 pandemic may impact future generations. This proposal builds on a project at Oregon Health & Science University (OHSU), which is harmonized with data collection efforts at seven geographically-representative sites from the NIH HEALthy Brains and Cognitive Development study (HBCD) initiative, including New York University, Washington University in St. Louis, University of Pittsburgh, Cedars Sinai Medical Center, University of Vermont and Northwestern University (R34 DA05029-S1). The OHSU site has exceeded enrollment targets for this initial project (N=371 versus the proposed N=100), successfully captured longitudinal trajectories of maternal stress and depressive symptoms during the early phase of the pandemic, and met targets for collection of biological samples and behavioral observations of mother-infant dyads (N=40). The OHSU site also serves as a central repository for biological samples collected at several other sites. The current proposal seeks to expand and enrich the sample at OHSU by enrolling pregnant individuals at heightened risk for substance use during the perinatal period (N=50). We additionally propose to expand biological sample collection of blood, breastmilk, hair, nails and saliva to include a larger sample of mothers and infants (N=100), and to occur at four time points (pregnancy, and infant age 1-, 6-, and 12-months). Finally, we propose to collect birth samples, umbilical cord blood and placenta, in a subsample of these participants (N=50). The continued follow up of our current sample, additional enrollment of higher-risk pregnant individuals and enhanced biological sampling will allow us to: 1) characterize trajectories of and heterogeneity in maternal perinatal psychological stress during the pandemic and identify key contributing factors differentiating subgroups; 2) advance understanding of the prevalence, longitudinal course and contributing factors to maternal perinatal substance use during the pandemic; and 3) test the hypothesis that heightened maternal-placental-fetal inflammation may serve as a common pathway for effects of maternal psychological stress and substance use on infant development. Accomplishing these aims will advance understanding of intergenerational transmission of risk during times of chronic stress and reduced resource availability, such as the COVID-19 pandemic. By enhancing capacity to examine contributors to maternal stress and substance use and mechanisms of impact on infant development, this work can also aide in identification of targets for preventive interventions to improve maternal and child health.", "keywords": [ "Address", "Adolescent and Young Adult", "Age", "Alcohols", "Behavior", "Behavior assessment", "Biological", "Biology", "Birth", "Blood", "Blood specimen", "Brain", "COVID-19 pandemic", "Child", "Child Development", "Chronic", "Chronic stress", "Collection", "Data Collection", "Development", "Economics", "Enrollment", "Environment", "Event", "Exposure to", "Future Generations", "Generations", "Geography", "Hair", "Health Resources", "Health Sciences", "Heterogeneity", "Human Milk", "Hydrocortisone", "Individual", "Individual Differences", "Infant", "Infant Behavior", "Infant Development", "Infection", "Inflammation", "Inflammatory", "Investigation", "Longitudinal cohort", "Marijuana", "Maternal Health", "Maternal and Child Health", "Measurement", "Measures", "Mediator of activation protein", "Medical", "Medical center", "Mental Health", "Mothers", "Nail plate", "Natural Disasters", "New York", "Oregon", "Participant", "Pathway interactions", "Perinatal", "Pharmaceutical Preparations", "Phase", "Placenta", "Postpartum Period", "Pregnancy", "Prevalence", "Psychological Stress", "Questionnaires", "Recording of previous events", "Research", "Resources", "Risk", "SARS-CoV-2 infection", "Saliva", "Sampling", "Site", "Social isolation", "Stress", "Stressful Event", "Subgroup", "Terrorism", "Testing", "Time", "Tobacco", "Trauma", "Umbilical Cord Blood", "United States National Institutes of Health", "Universities", "Variant", "Vermont", "Viral", "Washington", "Work", "antibody test", "behavior observation", "cognitive development", "cytokine", "demographics", "depressive symptoms", "fetal", "follow-up", "high risk", "improved", "infant outcome", "interest", "intergenerational", "longitudinal course", "longitudinal dataset", "maternal stress", "morphogens", "multimodality", "neurodevelopment", "offspring", "opioid exposure", "pandemic disease", "perinatal mental health", "perinatal period", "postnatal", "pregnant", "prenatal stress", "preventive intervention", "recruit", "repository", "sample collection", "social", "stress symptom", "stressor", "substance use", "symptomatology", "systemic inflammatory response", "transmission process" ], "approved": true } }, { "type": "Grant", "id": "6438", "attributes": { "award_id": "3R34DA050284-02S1", "title": "1/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "NIH Office of the Director" ], "program_reference_codes": [], "program_officials": [ { "id": 21627, "first_name": "Vani", "last_name": "Pariyadath", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-09-30", "end_date": "2021-03-31", "award_amount": 126761, "principal_investigator": { "id": 21628, "first_name": "DIMA", "last_name": "AMSO", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1416, "ror": "https://ror.org/01aw9fv09", "name": "Rhode Island Hospital", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 21629, "first_name": "Viren Andrew", "last_name": "D'Sa", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1416, "ror": "https://ror.org/01aw9fv09", "name": "Rhode Island Hospital", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true } ] }, { "id": 21630, "first_name": "Sean CL", "last_name": "Deoni", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, { "id": 21631, "first_name": "HANS-GEORG", "last_name": "MUELLER", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 1416, "ror": "https://ror.org/01aw9fv09", "name": "Rhode Island Hospital", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "/ DESCRIPTION Does maternal infection by the SARS-CoV-2 virus during pregnancy harm the developing fetal brain or increase the sensitivity to later developmental and environmental insults? he novel coronavirus (Covid-19) outbreak has fundamentally altered the child health landscape, ushering in sweeping changes in the social and economic fabric within which children grow. The rapidity of these environment changes, coupled with the relatively novelty of the SARS-CoV-2 virus and the widespread nature of infections, have presented multiple pressing questions. Among the unknowns that directly affect newborn and child health are: 1. How does Covid-19 infection during pregnancy effect the developing fetus or subsequent infant neurodevelopment? And 2. How will the unprecedented scale and scope of concurrent environmental changes impact child health and neurodevelopment? Unfortunately, over the course of the outbreak, the impact on children has been slow to be recognized with studies of Covid-19 infection or effects in infants and young children sparse to nonexistent. Moreover, while the health and economic impacts of the Covid-19 outbreak have been felt by everyone, the most severe effects have be felt by racial and ethnic minorities and lower income families. Thus, the most sensitive families and children already at risk for worsened neurodevelopmental outcomes are disproportionately and more intensely affected. Studies of newborns and infants are, therefore, critical to designing effective guidelines of care for expectant mothers, optimizing early care and support for mothers and their newborns, and prioritizing pre- and postnatal interventions. This supplement proposal aims to contribute important and timely evidence for these outcomes by characterizing neurodevelopmental profiles in infants born to mothers with and without antenatal Covid-19 infection, and examining the concurrent impact of social, economic, and substance use factors. Building on two existing and on-going studies of infant neurodevelopment (R34DA050284 and UH3OD023313), with deeply characterised longitudinal neuroimaging, neurocognitive, socioeconomic, demographic, psychosocial and biospecimen data, we will first investigate differences in brain structure, function, and connectivity development from birth to 1yr of age in infants born to mothers who were infected by the SARS-CoV-2 virus during pregnancy and born between May 1, and Sept. 1, 2020, compared to infants recruited at the same time but to non-infected mothers. We will also examine the impact of infection timing during pregnancy and symptom severity on brain measures. Next, we will compare these brain development trends to data from children who turned 1year old prior to Jan. 1, 2020, allowing us to examine the impact of specific environmental factors, including maternal and infant stress, nutrition, sleep health, and parent- child interaction that have changed due to outbreak-related lock-down and social distancing polices. We will further look at these environmental factors through a racial and socioeconomic lens, examining differences across race and income dimensions.", "keywords": [ "2019-nCoV", "Address", "Affect", "Age", "Age-Months", "Alcohol or Other Drugs use", "Birth", "Brain", "Breast Feeding", "COVID-19", "COVID-19 pandemic", "Caring", "Child", "Child Development", "Child Health", "Cognitive", "Contracts", "Coupled", "Data", "Databases", "Development", "Dimensions", "Disease Outbreaks", "Economics", "Employee", "Environment", "Environmental Risk Factor", "Family", "Family history of", "Fetal Development", "Fetus", "Fever", "Growth", "Guidelines", "Health", "Hydrocephalus", "Hyperthermia", "Hypoxemia", "Image", "Income", "Individual", "Infant", "Infection", "Inflammation", "Inflammatory Response", "Intervention", "Kangaroo", "Lead", "Learning", "Life", "Longitudinal Studies", "Low income", "Measures", "Mediating", "Mothers", "Nature", "Neurocognitive", "Neurologic", "Newborn Infant", "Outcome", "Parent-Child Relations", "Pattern", "Play", "Police", "Pregnancy", "Pregnant Women", "Premature Birth", "Race", "Regression Analysis", "Research", "Rhode Island", "Risk", "Risk Factors", "Role", "Safety", "Schools", "Services", "Severities", "Skin", "Sleep", "Smell Perception", "Social Distance", "Stress", "Stroke", "Structure", "Support Groups", "Symptoms", "Taste Perception", "Textiles", "Time", "Uncertainty", "Vertical Disease Transmission", "Virus", "antenatal", "antenatal care", "cognitive development", "cognitive function", "cytokine release syndrome", "design", "early life adversity", "economic impact", "educational atmosphere", "emerging adult", "environmental change", "environmental stressor", "ethnic minority population", "experience", "fetal", "health economics", "infection rate", "lens", "lower income families", "maternal stress", "neonate", "neurodevelopment", "neuroimaging", "novel coronavirus", "nutrition", "physical conditioning", "postnatal", "psychosocial", "racial and ethnic", "racial minority", "recruit", "sleep health", "sleep quality", "social", "sociodemographics", "socioeconomics", "treatment services", "trend" ], "approved": true } }, { "type": "Grant", "id": "7210", "attributes": { "award_id": "3R34DA050262-01S2", "title": "1/5, HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 10219, "first_name": "Vani", "last_name": "Pariyadath", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-09-30", "end_date": "2021-03-31", "award_amount": 154946, "principal_investigator": { "id": 22999, "first_name": "Karen M", "last_name": "Grewen", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 817, "ror": "", "name": "UNIV OF NORTH CAROLINA CHAPEL HILL", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 23000, "first_name": "Weili", "last_name": "Lin", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 817, "ror": "", "name": "UNIV OF NORTH CAROLINA CHAPEL HILL", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true }, "abstract": "The COVID-19 pandemic has affected the mental and physical health of children and their parents. The pandemic has also affected the ability to conduct in-person research at most institutions across the United States. However, recent technological advances may allow many in-person assessments to transition to virtual formats. There is an urgent need to develop virtual versions of currently used assessments of the home environment and parent-child interactions, and to concurrently study the effect of the COVID-19 pandemic on family relationships. The proposed project seeks to address this urgent need by building upon ongoing research efforts among three sites from the NIH HEALthy Brains and Cognitive Development (HBCD) study: Arkansas Children’s Research Institute, Cincinnati Children’s Hospital, and the University of North Carolina at Chapel Hill. We will develop and test a virtual version of the HOME Inventory in 90 mothers with infants between 6-18 months of age. We will validate this virtual version by performing in-person HOME Inventory assessments in 45 of these dyads. In all participants, we will use standard questionnaires to assess COVID-19 exposure and impact. Finally, we will examine associations between regional and temporal variations in COVID-19 exposure and impact and dimensions of the HOME Inventory. The results of this study will be used to finalize the development of a virtual HOME Inventory protocol that can be widely used in future studies, including the HBCD Phase II study.", "keywords": [ "Address", "Adult", "Affect", "Age-Months", "Anxiety", "Arkansas", "Behavior", "Brain", "COVID-19", "COVID-19 pandemic", "Child", "Child Development", "Child Health", "Child Rearing", "Cognitive", "Cohort Studies", "Development", "Dimensions", "Environment", "Equipment", "Equipment and supply inventories", "Family", "Family Relationship", "Future", "Geography", "Home environment", "Individual", "Infant", "Infection", "Institution", "Manuals", "Measurement", "Measures", "Mental Health", "Mothers", "North Carolina", "Parent-Child Relations", "Parents", "Participant", "Pediatric Hospitals", "Perinatal", "Persons", "Phase", "Protocols documentation", "Psychometrics", "Questionnaires", "Research", "Research Institute", "Safety", "Schools", "Site", "Stress", "Surveys", "Testing", "Time", "Training", "Transcend", "Uncertainty", "United States", "United States National Institutes of Health", "Universities", "Validation", "Variant", "Visit", "cognitive development", "cost", "experience", "innovation", "learning materials", "pandemic disease", "phase 1 study", "phase 2 study", "physical conditioning", "social", "virtual" ], "approved": true } }, { "type": "Grant", "id": "7531", "attributes": { "award_id": "3R34DA050287-01S2", "title": "1/7: Longitudinal evaluation of the impact of the COVID-19 pandemic on high-risk new and expectant mothers", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 10219, "first_name": "Vani", "last_name": "Pariyadath", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-09-30", "end_date": "2021-03-31", "award_amount": 186462, "principal_investigator": { "id": 20864, "first_name": "Veerle", "last_name": "Bergink", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 832, "ror": "", "name": "NEW YORK UNIVERSITY SCHOOL OF MEDICINE", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 20865, "first_name": "Moriah E", "last_name": "Thomason", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 832, "ror": "", "name": "NEW YORK UNIVERSITY SCHOOL OF MEDICINE", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": "The COVID-19 pandemic represents the most significant environmental event in living history and is leading to unprecedented social, economic and health consequences. There is an urgent need to longitudinally study the impact of the pandemic on pregnant women and the care they receive, and to understand the consequences for their children’s birth outcomes and neurobehavioral development. Importantly, women with pre -existing substance use, mental health conditions and limited economic resources may be at increased risk for the wide- ranging, deleterious sequelae of the pandemic. The proposed project seeks to address these critical gaps by building upon ongoing harmonized research efforts across seven geographically-representative sites from the NIH HEALthy Brains and Cognitive Development study (HBCD) initiative, including New York University, Oregon Health Sciences University, Washington University in St. Louis, University of Pittsburgh, Cedars Sinai Medical Center, University of Vermont and Northwestern University. We will enroll pregnant and postpartum women into a multi-wave study in which we assess medical, economic, psychosocial and substance use risk across pregnancy and the perinatal period, studying associations of these factors to infant neurobehavioral development during the first year of life. Our central hypotheses include: 1) individual variation in perinatal COVID-19 related stress leads to differences in birth outcomes, parenting stress and infant temperament and neurodevelopment and 2) substance use, mental health and economic risk enhance susceptibility to negative COVID-19 related health and psychosocial outcomes. To pursue these aims, prospective longitudinal survey, birth and postpartum data will be obtained across a 3-month period in N=100 pregnant and new mothers per site (providing a total consortium sample of N=700) to generate individual temporal profiles of COVID-19 related experiences and responses, comparing outcomes with existing data from maternal-infant cohorts obtained prior to the pandemic. Further, to identify avenues for intervention, will evaluate substance use, poor mental health and low social economic status as risk factors and coping, agency and utilization of resources as resilience factors that influence COVID-19 related maternal stress and child health and neurobehavioral outcomes. The effects of geographic location will be used to examine the influence of pandemic severity, variation in local government policies and resource availability on these outcomes. Finally, we will collect and bank longitudinal perinatal biospecimens in N=40 women per site that will provide a foundation for future studies to evaluate the biological mechanisms through which the effects on maternal psychological and physical health influence offspring brain and behavioral development. Through this analysis of COVID-19 related stress, contextual factors and child outcomes, we will develop comprehensive understanding of effects and modifiers of this event on health outcomes in individuals that vary in dispositional risk during perinatal life, one of the most sensitive timepoints in human development.", "keywords": [ "Address", "Alcohol or Other Drugs use", "Apgar Score", "Behavioral", "Biological", "Biological Specimen Banks", "Biology", "Birth", "Birth Records", "Brain", "COVID-19", "COVID-19 pandemic", "Caring", "Child", "Child Health", "Child Rearing", "Childhood", "Cognitive", "Collection", "Communities", "Coping Behavior", "Data", "Data Set", "Development", "Developmental Delay Disorders", "Economics", "Emotional", "Enrollment", "Equation", "Event", "Exposure to", "Factor Analysis", "Foundations", "Future", "Gene Expression", "Geographic Locations", "Geography", "Gestational Age", "Health", "Health Sciences", "Healthcare", "Human", "Human Development", "Impact evaluation", "Individual", "Infant", "Institution", "Intervention", "Life", "Local Government", "Longitudinal Studies", "Longitudinal Surveys", "Longitudinal prospective study", "Low Birth Weight Infant", "Medical Economics", "Medical center", "Mental Health", "Modeling", "Mothers", "New York", "Oregon", "Outcome", "Parents", "Perinatal", "Policies", "Postpartum Period", "Postpartum Women", "Predisposition", "Pregnancy", "Pregnant Women", "Protocols documentation", "Proxy", "Psychological Stress", "Recording of previous events", "Research", "Resources", "Risk", "Risk Factors", "Sampling", "Severities", "Site", "Social support", "Specimen", "Stress", "Structure", "Surveys", "Testing", "Time", "Uncertainty", "United States National Institutes of Health", "Universities", "Variant", "Vermont", "Viral", "Virus", "Vulnerable Populations", "Washington", "Woman", "Work", "behavioral health", "brain health", "cognitive development", "cohort", "contextual factors", "coping", "coronavirus disease", "experience", "health economics", "high risk", "improved", "indexing", "individual variation", "infant temperament", "inflammatory marker", "interest", "maternal stress", "maternal weight", "microbiome", "neurobehavioral", "neurodevelopment", "offspring", "pandemic disease", "perinatal period", "physical conditioning", "postnatal", "pregnant", "prenatal", "prospective", "protective factors", "psychosocial", "public health emergency", "resilience", "response", "secondary analysis", "social", "stressor" ], "approved": true } }, { "type": "Grant", "id": "12235", "attributes": { "award_id": "1R13AI179176-01", "title": "11th Annual Meeting of International Cytokine & Interferon Society", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 23719, "first_name": "Susan F.", "last_name": "Cooper", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-08-15", "end_date": "2024-07-31", "award_amount": 5000, "principal_investigator": { "id": 28108, "first_name": "James K", "last_name": "Turkson", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 766, "ror": "https://ror.org/02pammg90", "name": "Cedars-Sinai Medical Center", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true }, "abstract": "The purpose of this application is to request financial support for Cytokines 2023: 11th Annual Meeting of the International Cytokine & Interferon Society (ICIS), October,15-18, 2023, with llivestream and on-demand virtual access through October 29, 2023. This Annual Meeting helps bridge the gap between the scientists performing basic research on molecular and cellular mechanisms of immune cell activation and function with those working to develop this knowledge into novel therapies. The 11th edition comes at a time when cytokine biology, cytokine biomarkers and cytokine therapeutics are revolutionizing modern medicine, providing novel treatments for a wide variety of diseases ranging from lethal inflammatory, autoimmune and allergic diseases, to viral infections and cancer. This year’s theme is “Cytokines and interferons in the precision medicine era”, focusing on the latest developments on cytokine biology in relation to immune regulation, host damage and disease, and the latest progress on cytokines/cytokine inhibitors as novel therapeutics in the clinic. A variety of topics will be covered by leaders in the field in the plenary and parallel sessions such as innate immunity and host defense, adaptive immunity, cytokines in T and B cell responses to vaccination, in Long COVID, HIV and novel targeted therapies from cancer immunotherapy to novel therapeutics in autoimmunity. Since a major goal of the meeting is to promote interactions between scientists and clinicians working in basic, translational or applied research, ample opportunity will be given to poster networking sessions to present the latest advances elated to cytokine research, biomarkers and therapeutics. Greater understanding of mechanisms of disease and novel concepts for therapy have and will continue to emerge from interdisciplinary gatherings where advances can be presented and discussed by established and trainee scientists. The meeting will focus on cytokines in personalized medicine and will provide an opportunity for updates on the development of novel therapeutic interventions in these fields and help spur international collaborations among the meeting participants. Although meeting participants will have primary interests in infectious diseases, cancer and immune-mediated diseases, the program integrates speakers on the periphery of Cytokine and Interferon research to help bridge these disciplines. This interdisciplinary environment is particularly interesting for early career researchers who are not only focused on their own field of research but are beginning to think about the wider implications of their work. Our goal is to increase attendance of early career investigators and trainees and also to achieve higher representation of underrepresented minorities at all levels of career development. Online presentations will consist of livestreamed video presentations for all speakers who give their permission to be recorded, to benefit virtual attendees as well as in-person attendees to access content from parallel sessions or missed presentations. ICIS Meetings Committee and Council have decided that included virtual access even without travel restrictions, makes the Annual Meeting more inclusive and sustainable.", "keywords": [ "Allergic Disease", "Amaze", "Applications Grants", "Applied Research", "Arthritis", "Authorization documentation", "Autoimmune Diseases", "Autoimmunity", "Award", "B-Lymphocytes", "Basic Science", "Biological Markers", "Biology", "Biotechnology", "Budgets", "COVID-19", "COVID-19 impact", "Chronic Disease", "Clinic", "Clinical Research", "Collaborations", "Communicable Diseases", "Country", "Cytokine Network Pathway", "Data", "Development", "Diabetes Mellitus", "Discipline", "Disease", "Event", "Feedback", "Financial Support", "Future", "Goals", "Government", "Greece", "HIV", "Hawaii", "Health", "Host Defense", "Human", "Hybrids", "Immune", "Infection", "Inflammation", "Inflammatory", "Institution", "Interferons", "International", "Intuition", "Kidney Diseases", "Knowledge", "Lightning", "Lobbying", "Long COVID", "Love", "Malignant Neoplasms", "Mediating", "Modern Medicine", "Molecular", "Natural Immunity", "Parents", "Participant", "Persons", "Pharmacologic Substance", "Proteins", "Qualifying", "Reporting", "Research", "Research Personnel", "Rheumatoid Arthritis", "Role", "Scientist", "Societies", "Students", "T-Lymphocyte", "Therapeutic", "Time", "Translational Research", "Travel", "Underrepresented Minority", "Update", "Vaccination", "Viral Cancer", "Virus Diseases", "Work", "adaptive immunity", "cancer immunotherapy", "career", "career development", "collaborative environment", "cost", "cytokine", "design", "digital platform", "exhibitions", "flexibility", "fundamental research", "immune activation", "immunoregulation", "inhibitor", "interest", "live stream", "meetings", "multidisciplinary", "new therapeutic target", "novel", "novel therapeutic intervention", "novel therapeutics", "personalized medicine", "posters", "precision medicine", "programs", "response", "symposium", "targeted cancer therapy", "therapeutic target", "virtual", "virtual platform" ], "approved": true } }, { "type": "Grant", "id": "8358", "attributes": { "award_id": "1R13AI162177-01", "title": "11th IAS Conference on HIV Science (IAS 2021), Berlin, Germany, 18-21 July 2021", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "NIH Office of the Director" ], "program_reference_codes": [], "program_officials": [ { "id": 22396, "first_name": "Martin", "last_name": "Gutierrez", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-06-09", "end_date": "2022-05-31", "award_amount": 750000, "principal_investigator": { "id": 22397, "first_name": "Christopher C.", "last_name": "Beyrer", "orcid": null, "emails": "[email protected]", "private_emails": null, "keywords": "[]", "approved": true, "websites": "[]", "desired_collaboration": "", "comments": "", "affiliations": [ { "id": 1490, "ror": "", "name": "IAS", "address": "", "city": "", "state": "DC", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 8127, "first_name": "Adeeba", "last_name": "Kamarulzaman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 1490, "ror": "", "name": "IAS", "address": "", "city": "", "state": "DC", "zip": "", "country": "United States", "approved": true }, "abstract": "The scientific and public health response against HIV/AIDS in the past four decades has been remarkable and unprecedented. Yet HIV transmission continues in many populations at unacceptably high rates despite testing and treatment availability, largely driven by stigma and discrimination and other social and structural determinants. IAS 2021 will be the key global scientific convening to review progress against remaining challenges in controlling the epidemic. Significant new insights that are expected to be shared at IAS 2021 include basic work on virology, immunology and HIV pathogenesis with a continued focus on the functional cure/remission agenda. Clinical research in HIV is entering a new era of longer acting and injectable formulations which will be highlighted at IAS 2021, along with the remaining challenges of adherence, pill fatigue, and multi-drug resistant variants. Pediatric clinical care issues will be a further key topic where the advances in newer integrase inhibitor-based regimens for infants and children will be a primary focus. In the prevention field, the finding of superiority for long-acting injectable cabotegravir as PrEP marks the beginning of a new era, with further evidence expected in this regard at IAS 2021, along with early data on the co-formulations of long-acting injectables with other products for contraception, opioid dependence, and other health conditions. In the implementation science field innovative testing, prevention, treatment, and surveillance modalities will feature prominently at IAS 2021. Finally, the COVID-19 pandemic is expected to be among the defining themes across all scientific tracks against the background of treatment interruptions worldwide and the many remaining uncertainties regarding HIV/SARS- CoV-2 interactions. While the IAS is making parallel provisions for shifting to a fully virtual delivery format if mandated by the state of the COVID-19 pandemic, IAS 2021 is planned to take place in Berlin from 18-21 July 2021, with a strong virtual presence to ensure broad access (expected attendance of 6,000 delegates). It will provide a critical platform for HIV science to re-convene in a country now characterized by a celebration of diversity and zero discrimination. Berlin is at the heart of Europe, with close connectivity to the most HIV-affected region in Europe—Central and Eastern Europe, in particular Ukraine, and the Russian Federation, where, in marked contrast to Germany, rights-based approaches to HIV programming are constantly challenged. Specific aims of IAS 2021 are to: 1. Accelerate basic science and clinical innovation for the development and application of person-centered, precision medicine for HIV, including pathogenesis, transmission, vaccines, remission and a functional cure. 2. Advance inter-disciplinary collaboration in clinical research to improve integrated care across all life stages and accelerate updates to treatment guidance especially for low and middle-income countries, infected children, persons with HIV, TB, viral hepatitis and COVID-19 infection; 3. Strengthen HIV prevention research to improve biomedical, behavioral and structural interventions and the integration of new tools, including long-acting injectable prevention technologies in prevention programs for those in need; 4. Advance core components of the implementation science agenda across the HIV prevention-to-care cascade in the COVID-19 era, including aspects of integration and approaches for meaningful community engagement and resourcing health systems; 5. Address HIV vulnerability and determinants of disease progression among key and marginalized populations, including novel interventions and implementation science to reduce stigma and discrimination, including intersectional stigmas of HIV, other diseases, homophobia, transphobia, and ethnic and racial disparities. The scientific program will consist of four tracks: Track A – Basic Science; Track B – Clinical Science; Track C – Prevention Science; and Track D – Social, Behavioral, and Implementation Science. Cross-cutting aspects will be covered in plenary talks that also connect the scientific tracks with community and leadership perspectives, and bridging sessions will cut across at least two of the tracks to provide opportunities for multi-disciplinary dialogues. The participation of young researchers, basic scientists and researchers in related fields such as non- communicable diseases will be strengthened by active solicitation of relevant science and the provision of specific financial support, in addition to increased remote-access options.", "keywords": [ "2019-nCoV", "AIDS prevention", "AIDS/HIV problem", "Acquired Immunodeficiency Syndrome", "Address", "Adherence", "Adolescent and Young Adult", "Adult", "Affect", "Africa", "Africa South of the Sahara", "Age", "Aging", "Antiviral Agents", "Basic Science", "Behavioral", "Behavioral Sciences", "Berlin", "COVID-19", "COVID-19 pandemic", "COVID-19 vaccine", "Caring", "Child", "Childhood", "Chronic", "Cities", "Clinical", "Clinical Research", "Clinical Sciences", "Communities", "Complex", "Contraceptive Agents", "Contraceptive methods", "Counseling", "Country", "Coupled", "Data", "Development", "Discrimination", "Disease", "Disease Progression", "Disease remission", "Eastern Europe", "Emergency response", "Ensure", "Epidemic", "Europe", "Failure", "Fatigue", "Financial Support", "Formulation", "Fostering", "Futility", "Gays", "Germany", "HIV", "HIV Vaccine Trials Network", "HIV vaccine", "HIV/TB", "Health", "Health Resources", "Health Services Accessibility", "Health system", "Heart", "Homophobia", "Human", "Human immunodeficiency virus test", "Immunology", "Incidence", "Incidence Study", "Infant", "Infection", "Injectable", "Injecting drug user", "Integrase Inhibitors", "International AIDS", "Interruption", "Intervention", "Knowledge", "Leadership", "Life", "Minority", "Modality", "Morbidity - disease rate", "Multi-Drug Resistance", "Opiate Addiction", "Outcome", "Pathogenesis", "Patients", "Persons", "Population", "Positioning Attribute", "Prevention", "Prevention Research", "Prevention approach", "Prevention program", "Preventive vaccine", "Public Health", "Recording of previous events", "Regimen", "Relative Risks", "Reporting", "Research", "Research Personnel", "Resources", "Rights", "Risk Reduction", "SARS-CoV-2 infection", "Safety", "Science", "Scientist", "Social Sciences", "Structure", "Technology", "Testing", "Ukraine", "Uncertainty", "Update", "Vaccines", "Variant", "Viral hepatitis", "Virus Diseases", "War", "Woman", "Work", "base", "body system", "clinical care", "co-infection", "community engagement", "comorbidity", "density", "efficacy trial", "implementation science", "improved", "innovation", "insight", "interdisciplinary collaboration", "low and middle-income countries", "marginalized population", "men", "men who have sex with men", "mortality", "multidisciplinary", "novel", "pandemic disease", "patient oriented", "person centered", "pill", "pre-exposure prophylaxis", "precision medicine", "prevent" ], "approved": true } }, { "type": "Grant", "id": "11077", "attributes": { "award_id": "1R13AI176826-01", "title": "12th Biennial Symposium of the International Eosinophil Society, Inc. (IES)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 23719, "first_name": "Susan F.", "last_name": "Cooper", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-03-06", "end_date": "2024-02-29", "award_amount": 7000, "principal_investigator": { "id": 27050, "first_name": "Steven Jules", "last_name": "Ackerman", "orcid": null, "emails": "[email protected]", "private_emails": null, "keywords": "[]", "approved": true, "websites": "[]", "desired_collaboration": "", "comments": "", "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 1983, "ror": "", "name": "INTERNATIONAL EOSINOPHIL SOCIETY, INC.", "address": "", "city": "", "state": "WI", "zip": "", "country": "United States", "approved": true }, "abstract": "CONFERENCE ABSTRACT R13 conference support is requested for the 12th Biennial Eosinophil Symposium, “Eosinophils 2023”, to be held July 11-15, 2023 at the David Braley Health Sciences Centre, McMaster University, Hamilton, ON, Canada under the auspices of the International Eosinophil Society, Inc. (IES). The meeting hosts ~35 invited speakers and ~120 additional participants who submit abstracts. A cutting-edge program of basic, translational and clinical research is being prepared by the IES Scientific Program Committee in consultation with the Local Organizing Committee. Planned sessions include: 1) regulation of eosinophil development and trafficking, 2) eosinophils in tumor immunology and cancer therapy, 3) eosinophils in tissue injury/repair/fibrosis in organ disease, 4) eosinophil regulation of local immunity and interactions with innate and adaptive cells, 5) cell death (and stress, autophagy) in eosinophil biology, 6) reciprocal interactions between eosinophils and microbiomes in gut homeostasis/dysbiosis, 7) eosinophils in GI diseases, 8) eosinophils in host defense; anti-bacterial and viral responses including COVID-19, 9) eosinophils in dermatologic diseases, 10) novel technologies for studying eosinophils in health and disease, and 11) current status and future of eosinophils as therapeutic targets. The overarching goal is to provide a highly interactive, interdisciplinary forum for scientific exchange amongst junior and established scientists in the fields of allergy, immunology, microbiology, hematology, and cancer in relation to the eosinophil’s roles in health and disease. A primary objective is bringing together basic scientists with expertise in eosinophil biology, and clinician investigators interested in eosinophil-associated diseases, to improve understanding of disease mechanisms, significance of eosinophil functions, and foster translational research. A 2nd objective is to foster the development and interests of younger investigators to help support their career development, creating a new generation of “eosinophiles”. The meeting has a Keystone-like-structure with all participants in a single conference venue for unopposed sessions. Both the scientific and social programs emphasize creating a global community for eosinophil scientists. This meeting is particularly timely because new data and approvals of biologic therapies that directly or indirectly block eosinophil-mediated development and inflammatory pathways are now providing definitive findings on the roles of eosinophils in human health and disease. The symposium, with its strong emphasis on inter-disciplinary research, covers important global diseases including asthma, eosinophilic esophagitis, parasitoses, hypereosinophilic syndromes and COVID-19. The format includes plenary and poster sessions, with the former covering state-of-the-art topics by leaders in the field, followed by cutting edge presentations on recent high impact studies, with oral abstract presentations integrated into the sessions. Two unopposed poster sessions include short presentations of high-impact studies. Two prize lectures are included, the Ehrlich Award for a scientist who has made a major overall contribution to the field, and Gleich Award for a scientist with the highest impact publication over the previous two years.", "keywords": [ "Academy", "Address", "Alberta province", "Allergic", "American", "Animal Disease Models", "Animal Model", "Anti-Bacterial Agents", "Anti-Inflammatory Agents", "Asthma", "Autophagocytosis", "Award", "Basic Science", "Belgium", "Biochemistry", "Biological Response Modifier Therapy", "Biology", "COVID-19", "Canada", "Cell Death", "Cells", "Cellular biology", "Chicago", "Cities", "Clinical", "Clinical Investigator", "Clinical Research", "Clinical Treatment", "Clinical Trials", "Collaborations", "Communities", "Consultations", "Country", "Cutaneous", "Cytoprotection", "Data", "Dermatologic", "Development", "Diagnostic", "Diagnostic tests", "Disease", "Disseminated eosinophilic collagen disease", "Educational workshop", "Ensure", "Eosinophilic Esophagitis", "European", "Faculty", "Fertilization", "Fibrosis", "Fostering", "Future", "Generations", "Goals", "Health", "Health Sciences", "Hematology", "Homeostasis", "Host Defense", "Human", "Hypersensitivity", "Immunity", "Immunobiology", "Immunology", "In Vitro", "Infection", "Inflammatory", "Interdisciplinary Study", "International", "Leukocytes", "Malignant Neoplasms", "Mediating", "Metabolism", "Microbiology", "Mission", "Molecular", "Molecular Biology", "Normal tissue morphology", "Oral", "Organ", "Participant", "Pathogenesis", "Pathology", "Pathway interactions", "Patients", "Pharmaceutical Preparations", "Pharmacology", "Physiology", "Play", "Postdoctoral Fellow", "Prize", "Process", "Public Health", "Publications", "Quebec", "Regulation", "Research", "Research Personnel", "Role", "Scientist", "Series", "Societies", "Stress", "Structure", "Subgroup", "Sweden", "Switzerland", "Therapeutic", "Translational Research", "Underrepresented Minority", "United Kingdom", "Universities", "Viral", "Woman", "cancer therapy", "career", "career development", "dysbiosis", "eosinophil", "gastrointestinal", "graduate student", "gut homeostasis", "human disease", "improved", "in vivo", "injury and repair", "interest", "lectures", "meetings", "microbiome", "neoplastic", "new technology", "novel", "novel strategies", "posters", "programs", "research clinical testing", "response", "social", "sound", "symposium", "therapeutic target", "tissue injury", "trafficking", "tumor immunology", "wound healing" ], "approved": true } }, { "type": "Grant", "id": "6788", "attributes": { "award_id": "1R13FD007552-01", "title": "13th International Bordetella Symposium", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 22597, "first_name": "Madilyn", "last_name": "Gonzalez", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-04-01", "end_date": "2023-03-31", "award_amount": 15000, "principal_investigator": { "id": 22598, "first_name": "Fredrick Heath", "last_name": "Damron", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1093, "ror": "https://ror.org/011vxgd24", "name": "West Virginia University", "address": "", "city": "", "state": "WV", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1093, "ror": "https://ror.org/011vxgd24", "name": "West Virginia University", "address": "", "city": "", "state": "WV", "zip": "", "country": "United States", "approved": true }, "abstract": "Project Summary/Abstract: Whooping cough, also known as Pertussis, is a respiratory disease caused by the bacterial pathogen Bordetella pertussis. Pertussis is one of the world’s leading causes of vaccine-preventable deaths and is currently the only vaccine-preventable bacterial disease that is increasing in incidence. Despite high vaccine coverage, whooping cough (pertussis) has re-emerged as a major public health concern in the US and the world. Recently, it was estimated that there were 24 million pertussis cases and 160,700 deaths in children younger than 5 years around the world per year. In addition to being added to the NIH emerging infectious pathogens list in 2015, the CDC recently listed Bordetella pertussis on its new Watch List in the 2019 Antibiotic Resistance Threats Report because of the unknown future burden of this highly contagious bacterium. Since the 1960’s, the Bordetella research community has organized an International Bordetella Symposium, the 12th symposium was hosted at Brussels University by Dr. Camille Locht, in April of 2019. In an effort to increase dissemination of new data and exchange of ideas, Dr. Ciaran Skerry hosted the 1st ever Bordetella Research Day at the University of Maryland in April, 2018. The Bordetella Research Day was meant to be a U.S-based conference for Bordetella researchers to meet during the off years of the International Bordetella Symposiums. Due to the COVID-19 pandemic, both the 2020 Bordetella Research Day, and the 2021 International Bordetella Symposium were postponed. To continue dissemination of important research, the International Bordetella Society hosted a zoom-based conference in August 2020 which garnered attendance from academia, the CDC, FDA, NIH, and many pharmaceutical companies. The major success of this online event resulted in the Bordetella Society creating a monthly Lab Meeting Series, where different groups around the world can showcase their latest research. In order to further support the development of the next generation of scientists, this R13 application is requesting funds from the FDA Center for Biologics Evaluations and Research (CBER) to support travel associated costs for junior scientists (pre- and post-doctoral) to attend and present innovative research at the 13th International Bordetella Symposium hosted at the University of British Columbia in Vancouver, Canada (June 2022).", "keywords": [], "approved": true } }, { "type": "Grant", "id": "3239", "attributes": { "award_id": "1824680", "title": "13th International Congress on the Biology of Fish - Student Travel Grants, Calgary, Canada, July 15-19, 2018", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Biological Sciences (BIO)", "Physiolgcl Mechnsms&Biomechnsm" ], "program_reference_codes": [], "program_officials": [ { "id": 10192, "first_name": "Kathryn", "last_name": "Dickson", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2018-07-01", "end_date": "2019-06-30", "award_amount": 15000, "principal_investigator": { "id": 10193, "first_name": "Christopher", "last_name": "Myrick", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 323, "ror": "https://ror.org/03k1gpj17", "name": "Colorado State University", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 323, "ror": "https://ror.org/03k1gpj17", "name": "Colorado State University", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true }, "abstract": "Fishes, with over 33,000 known species, are a primary global food source and serve as indicators of environmental quality. The Physiology Section of the American Fisheries Society (AFS) is hosting the 13th International Congress on the Biology of Fish in Calgary, Canada, in July 2018. This award provides financial assistance for undergraduate and graduate students traveling to the 2018 Congress. The AFS Congress will be attended by high caliber fish biologists from over 30 countries who will present in 18 symposia on topics ranging from basic science (e.g., shark physiology) to applied science (e.g., sewage impacts on fish), and serves as an incubator for collaboration and idea exchange. Of greater importance is the opportunity the Congress provides to over 150 student and post-doctoral researchers who will present their work and interact with a large and diverse group of fish biology researchers. Congress organizers aim to continue to foster success of young scientists from groups under-represented in STEM and Fish Physiology. Students who receive travel support from this award will be selected based on the scientific quality of their abstract, the relevance of their subject matter to the symposia, and financial need. The Congress more broadly promotes development of a strong scientific infrastructure, by incorporating professional development activities for a diverse group of junior scientists. In addition to research presentations, the travel grant recipients will be able to attend student-oriented support sessions held throughout the Congress, including specific mentoring and career events, and socials aimed at helping students develop professional networks. \n\nThe Physiology Section of the American Fisheries Society has hosted the biennial International Congress on the Biology of Fish since 1994, and is hosting the 13th International Congress on the Biology of Fish in Calgary, Canada, on July 15-19, 2018. This award provides financial travel assistance to undergraduate and graduate students who participate in the Congress, based on the quality of their research and financial need. The Congress is the premiere venue for fish physiology researchers and represents an opportunity for the fish physiology community to learn about cutting-edge research throughout the world. The 2018 Congress is organized into 18 Symposia, hosted by subject matter experts, covering a wide array of topics and levels of biological organization from the molecular to the ecosystem. The Congress historically includes a strong student contingent whose members consistently deliver excellent presentations. Additionally, the ethnically and culturally diverse collection of fish biologists at the Congress affords students an excellent opportunity to interact with subject matter experts and to identify potential career mentors, which is of great importance for early career scientists, especially those from under-represented groups. The Congress includes student-targeted events for mentoring and career events focused on helping foster the future success of students as they move into the next phase of their careers. Free Congress proceedings will be available on the AFS Physiology Section website.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } } ], "meta": { "pagination": { "page": 3, "pages": 1392, "count": 13920 } } }